European Journal of Radiology
Volume 54, Issue 1 , Pages 6-14 , April 2005

Normal and pathological breast, the histological basis

  • J.M. Guinebretière

      Affiliations

    • Department of Pathology, Centre René-Huguenin, 35 rue Dailly, 92210 Saint Cloud, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 1 47 11 15 10; fax: +33 1 47 11 15 16.
    • ,
  • E. Menet

      Affiliations

    • Department of Pathology, Centre René-Huguenin, 35 rue Dailly, 92210 Saint Cloud, France
    • ,
  • A. Tardivon

      Affiliations

    • Department of Radiology, Institut Curie, 26 rue d’Ulm, 75248 Paris Cédex 5, France
    • ,
  • P. Cherel

      Affiliations

    • Department of Radiology, Centre René-Huguenin, 35 rue Dailly, 92210 Saint Cloud, France
    • ,
  • D. Vanel

      Affiliations

    • Department of Diagnostic Radiology, Institut Gustave-Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France

Received 22 November 2004 ,Revised 26 November 2004 ,Accepted 29 November 2004.

Reference 

  1. Vogel PM, Georgiade NG, Fetter BF, Vogel FS, McCarty KS. The correlation of histologic changes in the human breast with the menstrual cycle. Am J Pathol. 1981;104:23–34
  2. Gompel A, Martin A, Simon P, et al. Epidermal growth factor receptor and c-erbB-2 expression in normal breast tissue during the menstrual cycle. Breast Cancer Res Treat. 1996;38:227–235
  3. Sabourin JC, Martin A, Baruch J, Truc JB, Gompel A, Poitout P. bcl-2 expression in normal breast tissue during the menstrual cycle. Int J Cancer. 1994;59:1–6
  4. Ashton MA, Lefkowitz M, Tavassoli FA. Epithelioid stromal cells in lymphocytic mastitis—a source of confusion with invasive carcinoma. Mod Pathol. 1994;7:49–54
  5. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative disease. N Engl J Med. 1985;312:146–151
  6. Fitzgibbons PL, Henson DE, Hutter RV. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med. 1998;122:1053–1055
  7. Frouge C, Tristant H, Guinebretiere JM, et al. Mammographic lesions suggestive of radial scars: microscopic findings in 40 cases. Radiology. 1995;195:623–625
  8. Sloane JP, Mayers MM. Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: importance of lesion size and patient age. Histopathology. 1993;23:225–231
  9. Noguchi S, Motomura K, Inaji H, Imaoka S, Koyama H. Clonal analysis of fibroadenoma and phyllodes tumour of the breast. Cancer Res. 1993;53:4071–4074
  10. Rosen PP, Lieberman PH, Braun DW, Kolsoff C, Adair F. Lobular carcinoma in situ of the breast: detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol. 1978;2:225–251
  11. Schnitt SJ, Morrow M. Lobular carcinoma in situ: current concepts and controversies. Semin Diagn Pathol. 1999;16:209–223
  12. Contesso G, Petit JY. Non-infiltrating intraductal carcinoma of the breast. Bull Cancer. 1979;66:1–8
  13. Holland R, Peterse JL, Millis RR, et al. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol. 1994;11:167–180
  14. Silverstein MJ, Poller DN, Waisman JR, et al. Prognostic classification of breast ductal carcinoma-in situ. Lancet. 1995;345:1154–1157
  15. Tavassoli FA. Ductal intraepithelial neoplasia of the breast. Virchows Arch. 2001;438:221–227
  16. Faverly DR, Burgers L, Bult P, Holland R. Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol. 1994;11:193–198
  17. Baxter NN, Virnig BA, Durham SB, Tuttle TM. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2004;96:443–448
  18. Cutuli B, Cohen-Solal-Le Nir C, De Lafontan B, et al. Ductal carcinoma in situ of the breast results of conservative and radical treatments in 716 patients. Eur J Cancer. 2001;37:2365–2372
  19. Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer. 1999;86:429–438
  20. Julien JP, Bijker N, Fentiman IS, et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomized phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet. 2000;355:528–533
  21. Silverstein MJ, Lagios MD, Groshen S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med. 1999;340:1455–1461
  22. Contesso G, Bertin F, Mathieu MC, Terrier P. Anatomie pathologique des cancers mammaires. Ed Tech Encyc Méd Chir. 1991;865(B10):16

PII: S0720-048X(05)00015-X

doi: 10.1016/j.ejrad.2004.11.020

European Journal of Radiology
Volume 54, Issue 1 , Pages 6-14 , April 2005

Article Tools

* Image Usage & Resolution